Article Details

Allogene, Overland Form Joint Venture to Advance Allogenic CAR T Cell Therapies in China

Retrieved on: 2020-12-15 19:30:00

Tags for this article:

Click the tags to see associated articles and topics

Allogene, Overland Form Joint Venture to Advance Allogenic CAR T Cell Therapies in China. View article details on hiswai:

Excerpt

A statement made by the companies noted Overland will invest approximately $117 million in <b>capital</b> in the project, including an upfront $40 million ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up